Product NDC: | 16590-544 |
Proprietary Name: | CYCLOBENZAPRINE HYDROCHLORIDE |
Non Proprietary Name: | CYCLOBENZAPRINE HYDROCHLORIDE |
Active Ingredient(s): | 5 mg/1 & nbsp; CYCLOBENZAPRINE HYDROCHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 16590-544 |
Labeler Name: | STAT RX USA LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA071611 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100429 |
Package NDC: | 16590-544-62 |
Package Description: | 84 TABLET in 1 BOTTLE (16590-544-62) |
NDC Code | 16590-544-62 |
Proprietary Name | CYCLOBENZAPRINE HYDROCHLORIDE |
Package Description | 84 TABLET in 1 BOTTLE (16590-544-62) |
Product NDC | 16590-544 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CYCLOBENZAPRINE HYDROCHLORIDE |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20100429 |
Marketing Category Name | ANDA |
Labeler Name | STAT RX USA LLC |
Substance Name | CYCLOBENZAPRINE HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |